Early research (Phase 1)UnknownNCT05352646
What this trial is testing
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Who this might be right for
Hepatocellular Carcinoma
Newish Technology (Beijing) Co., Ltd. 26
Showing 20 of 0 results